Top

Published in:

30-01-2023 | Care | Original Paper

The Impact of COVID-19 on HIV Care in Rio de Janeiro, Brazil 2019–2021: Disparities by Age and Gender

Authors: Anne E. Bocage, Lara E. Coelho, Jordan E. Lake, Jesse L. Clark, Thiago S. Torres, Emília M. Jalil, Sandra W. Cardoso, Ronaldo I. Moreira, Valdilea G. Veloso, Beatriz Grinsztejn, Paula M. Luz

Published in: AIDS and Behavior | Issue 8/2023

Abstract

We evaluated COVID-19’s impact on HIV care indicators among INI/FIOCRUZ’s HIV Clinical Cohort in Rio de Janeiro, Brazil: (1) Adequate care visits: two visits ≥ 90 days apart; (2) Adequate viral load monitoring: ≥ 2 viral load results ≥ 90 days apart; (3) Consistent viral suppression: all viral loads < 40 copies/mL; and (4) ART medication possession ratio (MPR) ≥ 95%. Chi-square tests compared the fraction of participants meeting each indicator per period: pre-pandemic (3/1/2019–2/29/2020) and post-pandemic (3/1/2020–2/28/2021). Logistic regression models were used to assess disparities in adequate care visits. Among 906 participants, care visits and viral load monitoring decreased pre-pandemic to post-pandemic: 77.0–55.1% and 36.6–11.6% (both p < 0.001), respectively. The optimal MPR rate improved from 25.5 to 40.0% (p < 0.001). Post-pandemic period (aOR 0.33, CI 0.28–0.40), transgender women (aOR 0.34, CI 0.22–0.53), and those aged 18–24 years (aOR 0.67, CI 0.45–0.97) had lower odds of adequate care visits. COVID-19 disrupted care access disproportionately for transgender women and younger participants.

Available only for authorised users

Medland NA, Mcmahon JH, Chow EP, Elliott JH, Hoy JF, Fairley CK. The HIV care cascade: a systematic review of data sources, methodology and comparability. J Int AIDS Soc. 2015. https://doi.org/10.7448/IAS.18.1.20634.CrossRefPubMedPubMedCentral

da Rocha ABM, Barros C, Generoso IP, Bastos FI, Veras MA. HIV continuum of care among trans women and travestis living in São Paulo, Brazil. Rev Saude Publica. 2020;54:118. https://doi.org/10.11606/s1518-8787.2020054002374.CrossRefPubMedPubMedCentral

Grinsztejn B, Jalil EM, Monteiro L, Velasque L, Moreira RI, Garcia ACF, et al. Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil. Lancet HIV. 2017;4(4):e169–76. https://doi.org/10.1016/S2352-3018(17)30015-2.CrossRefPubMedPubMedCentral

Jalil EM, Wilson EC, Luz PM, Velasque L, Moreira RI, Castro CV, et al. HIV testing and the care continuum among transgender women: population estimates from Rio de Janeiro, Brazil: population. J Int AIDS Soc. 2017;20(1):21873. https://doi.org/10.7448/IAS.20.1.21873.CrossRefPubMedPubMedCentral

Roberta A, Pascom P, Meireles MV, Benzaken AS. Sociodemographic determinants of attrition in the HIV continuum of care in Brazil, in 2016. Medicine. 2018. https://doi.org/10.1097/MD.0000000000009857.CrossRef

Shimocomaqui GB, Meyer CS, Ikeda ML, Romeu Farias E, Gonçalves TR, Rutherford GW, et al. Factors associated with HIV care and treatment cascade in Rio Grande do Sul, Brazil, 2014–2017: a cross-sectional study. Int J STD AIDS. 2021;32(5):462–9. https://doi.org/10.1177/0956462420975947.CrossRefPubMed

WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) dashboard with vaccination data [Internet]. [cited 2022 Nov 4]. Available from: https://covid19.who.int/.

Burstrom B, Tao W. Social determinants of health and inequalities in COVID-19. Eur J Public Health. 2020;30(4):617. https://doi.org/10.1093/eurpub/ckaa095.CrossRefPubMed

Rocha R, Atun R, Massuda A, Rache B, Spinola P, Nunes L, et al. Effect of socioeconomic inequalities and vulnerabilities on health-system preparedness and response to COVID-19 in Brazil: a comprehensive analysis. Lancet Global Health. 2021;9(6):e782–92. https://doi.org/10.1016/S2214-109X(21)00081-4.CrossRefPubMed

10.

Rocha SQ, Avelino-Silva VI, Tancredi MV, Jamal LF, Ferreira PRA, Tayra A, et al. COVID-19 and HIV/AIDS in a cohort study in Sao Paulo, Brazil: outcomes and disparities by race and schooling. AIDS Care. 2021. https://doi.org/10.1080/09540121.2021.1936444.CrossRefPubMed

11.

Siewe Fodjo JN, de Moura Villela EF, Van Hees S, Dos Santos TT, Vanholder P, Reyntiens P, et al. Impact of the COVID-19 pandemic on the medical follow-up and psychosocial well-being of people living with HIV: a cross-sectional survey. J Acquir Immune Defic Syndr. 2020;85(3):257–62. https://doi.org/10.1097/QAI.0000000000002468.CrossRefPubMed

12.

Baqui P, Bica I, Marra V, Ercole A, van der Schaar M. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Global Health. 2020;8(8):e1018–26. https://doi.org/10.1016/S2214-109X(20)30285-0CrossRefPubMed

13.

Grinsztejn B, Veloso VG, Friedman RK, Moreira RI, Luz PM, Campos DP, et al. Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS. 2009;23(16):2107. https://doi.org/10.1097/QAD.0b013e32832ec494.CrossRefPubMed

14.

Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas para Manejo da infecção pelo HIV me Adultos [Internet]. Brasilia; 2018 [cited 2022 Jun 9]. Available from: https://prceu.usp.br/wp-content/uploads/2020/05/pcdt_adulto_12_2018_web1.pdf.

15.

Lee E, Kim J, Bang JH, Lee JY. Suboptimal medication adherence in young women living with HIV infection: a Korean nationwide claims study. AIDS Care. 2021;33(7):938–42. https://doi.org/10.1080/09540121.2020.1844863.CrossRefPubMed

16.

Hirsch JD, Gonzales M, Rosenquist A, Miller TA, Gilmer TP, Best BM. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS. J Manag Care Pharm. 2011;17(3):213–23. https://doi.org/10.18553/jmcp.2011.17.3.213.CrossRefPubMed

17.

Kim J, Lee E, Park BJ, Bang JH, Lee JY. Adherence to antiretroviral therapy and factors affecting low medication adherence among incident HIV-infected individuals during 2009–2016: a nationwide study. Sci Rep. 2018. https://doi.org/10.1038/s41598-018-21081-x.CrossRefPubMedPubMedCentral

18.

Instituto Brasileiro de Geografia e Estatística. Características étnico-raciais da população : um estudo das categorias de classificação de cor ou raça: 2008/IBGE, Coordenação de População de Indicadores Sociais. [Internet]. IBGE, editor. Rio de Janeiro; 2011 [cited 2022 May 27]. p. 1–99. Available from: https://biblioteca.ibge.gov.br/index.php/biblioteca-catalogo?view=detalhes&id=249891.

19.

Halekoh U, Højsgaard S, Yan J. The R package geepack for generalized estimating equations. J Stat Softw. 2006;15(2):1–11.CrossRef

20.

R: the R project for statistical computing [Internet]. [cited 2022 May 27]. Available from: https://www.r-project.org/.

21.

Lee JA, Kim Y, Choi JY. Impact of the COVID-19 pandemic on HIV services in Korea: results from a cross-sectional online survey. Infect Chemother. 2021;53(4):741. https://doi.org/10.3947/ic.2021.0112.CrossRefPubMedPubMedCentral

22.

Quiros-Roldan E, Magro P, Carriero C, Chiesa A, El HI, Tratta E, et al. Consequences of the COVID-19 pandemic on the continuum of care in a cohort of people living with HIV followed in a single center of Northern Italy. AIDS Res Ther. 2020;17:59. https://doi.org/10.1186/s12981-020-00314-y.CrossRefPubMedPubMedCentral

23.

Norwood J, Kheshti A, Shepherd BE, Rebeiro PF, Ahonkhai A, Kelly S, et al. The impact of COVID-19 on the HIV care continuum in a large urban southern clinic. AIDS Behav. 2022;1:1. https://doi.org/10.1007/s10461-022-03615-7.CrossRefPubMedPubMedCentral

24.

Rick F, Odoke W, van den Hombergh J, Benzaken AS, Avelino-Silva VI. Impact of coronavirus disease (COVID-19) on HIV testing and care provision across four continents. HIV Med. 2022;23(2):169–77. https://doi.org/10.1111/hiv.1318010.1111/hiv.13180.CrossRefPubMed

25.

Lesko CR, Keruly JC, Moore RD, Shen NM, Pytell JD, Lau B, et al. COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022. https://doi.org/10.1016/j.drugalcdep.2022.109355.CrossRefPubMedPubMedCentral

26.

Maintaining essential health services: operational guidance for the COVID-19 context, interim guidance, 1 June 2020 [Internet]. [cited 2022 May 27]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-essential_health_services-2020.2.

27.

Izzo I, Carriero C, Gardini G, Fumarola B, Chiari E, Castelli F, et al. Impact of COVID-19 pandemic on HIV viremia: a single-center cohort study in northern Italy. AIDS Res Ther. 2021;18(1):1–5. https://doi.org/10.1186/s12981-021-00355-x.CrossRef

28.

Sun Y, Li H, Luo G, Meng X, Guo W, Fitzpatrick T, et al. Antiretroviral treatment interruption among people living with HIV during COVID-19 outbreak in China: a nationwide cross-sectional study. J Int AIDS Soc. 2020;23(11):e25637. https://doi.org/10.1002/jia2.25637.CrossRefPubMedPubMedCentral

29.

Torres TS, Hoagland B, Bezerra DRB, Garner A, Jalil EM, Coelho LE, et al. Impact of COVID-19 pandemic on sexual minority populations in Brazil: an analysis of social/racial disparities in maintaining social distancing and a description of sexual behavior. AIDS Behav. 2021;25(1):73–84. https://doi.org/10.1007/s10461-020-02984-1.CrossRefPubMed

30.

Costa AB, Fontanari AMV, Catelan RF, Schwarz K, Stucky JL, da Rosa Filho HT, et al. HIV-related healthcare needs and access barriers for Brazilian transgender and gender diverse people. AIDS Behav. 2018;22(8):2534–42. https://doi.org/10.1007/s10461-017-2021-1.CrossRefPubMed

31.

Tomar A, Spadine MN, Graves-Boswell T, Wigfall LT. COVID-19 among LGBTQ+ individuals living with HIV/AIDS: psycho-social challenges and care options. AIMS Public Health. 2021;8(2):303–8. https://doi.org/10.3934/publichealth.2021023.CrossRefPubMedPubMedCentral

32.

Chen YT, Duncan DT, Del Vecchio N, Timmins L, Pagkas-Bather J, Lacap S, et al. COVID-19-related stressors, sex behaviors, and HIV status neutral care among Black men who have sex with men and transgender women in Chicago, USA. J Acquir Immune Defic Syndr. 2021;88(3):261–271. https://doi.org/10.1097/QAI.0000000000002770.CrossRefPubMedPubMedCentral

33.

Poteat TC, Reisner SL, Miller M, Wirtz AL. Letter to the editor: vulnerability to COVID-19-related harms among transgender women with and without HIV infection in the eastern and southern U.S. J Acquir Immune Defic Syndr. 2020;85(4):e67–e69. https://doi.org/10.1097/QAI.0000000000002490.CrossRefPubMedPubMedCentral

34.

Garcia Ferreira AC, Esteves Coelho L, Jalil EM, Luz PM, Friedman RK, Guimarães MRC, et al. Transcendendo: a cohort study of HIV-infected and uninfected transgender women in Rio de Janeiro, Brazil. Transgender Health. 2019;4(1):107–117. https://doi.org/10.1089/trgh.2018.0063.CrossRef

35.

Abrams EM, Szefler SJ. COVID-19 and the impact of social determinants of health. Lancet Respir Med. 2020;8(7):659–661. https://doi.org/10.1016/S2213-2600(20)30234-4.CrossRefPubMedPubMedCentral

36.

de Oliveira BLCA, Luiz RR. Mortality by skin color/race and urbanity of Brazilian cities. Ethn Health. 2017;22(4):372–88. https://doi.org/10.1080/13557858.2016.1244625.CrossRefPubMed

37.

Constante HM, Bastos JL. Mapping the margins in health services research: how does race intersect with gender and socioeconomic status to shape difficulty accessing HealthCare among unequal Brazilian states? Int J Health Serv. 2020;51(2):155–66. https://doi.org/10.1177/0020731420979808.CrossRefPubMed

38.

Bogart LM, Ojikutu BO, Tyagi K, Klein DJ, Mutchler MG, Dong L, et al. COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among Black Americans living with HIV. J Acquir Immune Defic Syndr. 2021;86(2):200–7. https://doi.org/10.1097/QAI.0000000000002570.CrossRefPubMed

39.

El-Nahal WG, Shen NM, Keruly JC, Jones JL, Fojo AT, Manabe YC, Moore RD, Gebo KA, Chander G, Lesko CR. Time between viral loads for people with HIV during the COVID-19 pandemic. J Acquir Immune Defic Syndr. 2022;91(1):109–116. https://doi.org/10.1097/QAI.0000000000003026.

40.

Althoff KN, Stewart CN, Humes E, Zhang J, Gerace L, Boyd CM, et al. The shifting age distribution of people with HIV using antiretroviral therapy in the United States. AIDS. 2022;36(3):459–71. https://doi.org/10.1097/QAD.0000000000003128.CrossRefPubMed

41.

Govender RD, Hashim MJ, Khan MA, Mustafa H, Khan G. Global epidemiology of HIV/AIDS: a resurgence in North America and Europe. J Epidemiol Glob Health. 2021;11(3):296–301. https://doi.org/10.2991/jegh.k.210621.001.CrossRefPubMedPubMedCentral

42.

Spinelli MA, Hickey MD, Glidden DV, Nguyen JQ, Oskarsson JJ, Havlir D, et al. Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19. AIDS. 2020;34(15):2328–31. https://doi.org/10.1097/QAD.0000000000002677.CrossRefPubMed

43.

Qian L, Sy LS, Hong V, Glenn SC, Ryan DS, Morrissette K, et al. Disparities in outpatient and telehealth visits during the COVID-19 pandemic in a large integrated health care organization: retrospective cohort study. J Med Internet Res. 2021;23(9):e29959. https://doi.org/10.2196/29959.CrossRefPubMedPubMedCentral

44.

Rezende LFM, Thome B, Schveitzer MC, de Souza-Júnior PRB, Szwarcwald CL. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil. Rev Saude Publica. 2020;54:50. https://doi.org/10.11606/s1518-8787.2020054002596.CrossRefPubMedPubMedCentral

45.

Cueto M, Lopes G. Backlash in global health and the end of AIDS’ exceptionalism in Brazil, 2007–2019. Glob Public Health. 2021. https://doi.org/10.1080/17441692.2021.1896764.CrossRefPubMed

46.

Parker R. AIDS crisis and Brazil. Oxford Res Encycl Lat Am Hist. 2020. https://doi.org/10.1093/acrefore/9780199366439.013.865.CrossRef

47.

Relatório de Monitoramento Clínico do HIV 2020 | Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis [Internet]. 2021 Nov [cited 2022 May 27]. Available from: http://www.aids.gov.br/pt-br/pub/2020/relatorio-de-monitoramento-clinico-do-hiv-2020.

48.

Tripepi G, Jager KJ, Dekker FW, Zoccali C. Selection bias and information bias in clinical research. Nephron Clin Pract. 2010;115(2):c94–9. https://doi.org/10.1159/000312871.CrossRefPubMed

49.

Hoagland B, Torres TS, Bezerra DRB, Geraldo K, Pimenta C, Veloso VG, et al. Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil. Braz J Infect Dis. 2020;24(4):360–4. https://doi.org/10.1016/j.bjid.2020.05.004.CrossRefPubMedPubMedCentral

50.

Hoagland B, Torres TS, Bezerra DRB, Benedetti M, Pimenta C, Veloso VG, et al. High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil. Braz J Infect Dis. 2021. https://doi.org/10.1016/j.bjid.2020.11.002.CrossRefPubMed

51.

Pereira GFM. Brazil sustains HIV response during the COVID-19 pandemic. Lancet HIV. 2021;8(2):e65. https://doi.org/10.1016/S2352-3018(21)00003-5.CrossRefPubMed

52.

Refugio ON, Kimble MM, Silva CL, Lykens JE, Bannister C, Klausner JD. Brief report: PrEPTECH: a telehealth-based initiation program for HIV pre-exposure prophylaxis in young men of color who have sex with men. A pilot study of feasibility. J Acquir Immune Defic Syndr. 2019;80(1):40–5. https://doi.org/10.1097/QAI.0000000000001873.CrossRefPubMedPubMedCentral

53.

Bezerra DRB, Jalil CM, Jalil EM, Coelho LE, Carvalheira E, Freitas J, et al. Complementary recruitment strategies to reach men who have sex with men and transgender women: the experience of a large Brazilian HIV prevention service. AIDS Behav. 2022;26(8):2643–52. https://doi.org/10.1007/s10461-022-03609-5.CrossRefPubMed

Title: The Impact of COVID-19 on HIV Care in Rio de Janeiro, Brazil 2019–2021: Disparities by Age and Gender
Authors: Anne E. Bocage
Lara E. Coelho
Jordan E. Lake
Jesse L. Clark
Thiago S. Torres
Emília M. Jalil
Sandra W. Cardoso
Ronaldo I. Moreira
Valdilea G. Veloso
Beatriz Grinsztejn
Paula M. Luz
Publication date: 30-01-2023
Publisher: Springer US
Keywords: Care
Human Immunodeficiency Virus
COVID-19
Published in: AIDS and Behavior / Issue 8/2023
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-023-03988-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2023

Stigma and HIV Treatment Outcomes Among Transgender Women Sex Workers in the Dominican Republic

Psychosocial Protective and Risk Factors of Quality of Life Outcomes Among Older Adults Living With HIV

Characterization of HIV-Related Stigma in Myanmar

Risks of Intimate Partner Violence for Women Living with HIV Receiving Cash Transfers: A Qualitative Study in Shinyanga, Tanzania

Socio-ecological Barriers to Viral Suppression Among Transgender Women Living with HIV in San Francisco and Los Angeles, California

Understanding Barriers and Facilitators of Pre-exposure Prophylaxis (PrEP) Among Transgender and Gender Diverse Adults in an Integrated Health Care System

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage